Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sreenath V Sharma

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Genes & Development|December 15, 2007
Oncogene addiction: setting the stage for molecularly targeted cancer therapySreenath V Sharma, Jeffrey Settleman
Cell Cycle (Georgetown, Tex.)|January 16, 2007
Oncogenic shock: turning an activated kinase against the tumor cellSreenath V Sharma, Jeffrey Settleman
Experimental Cell Research|August 30, 2008
ErbBs in lung cancerSreenath V Sharma, Jeffrey Settleman
Biochemical Pharmacology|March 10, 2010
Exploiting the balance between life and death: targeted cancer therapy and "oncogenic shock"Sreenath V Sharma, Jeff Settleman
Oncogene|April 18, 2002
UCS15A, a novel small molecule, SH3 domain-mediated protein-protein interaction blocking drugChitose Oneyama, Hirofumi Nakano, Sreenath V Sharma
Methods in Enzymology|April 17, 2008
High-throughput lung cancer cell line screening for genotype-correlated sensitivity to an EGFR kinase inhibitorUltan McDermott, Sreenath V Sharma, Jeffrey Settleman
Cell Cycle (Georgetown, Tex.)|October 9, 2010
Allosteric inhibition of BCR-ABLA Quamrul Hassan, Sreenath V Sharma, Markus Warmuth
Nature Reviews. Cancer|March 20, 2010
Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agentsSreenath V Sharma, Daniel A Haber, Jeff Settleman
Current Cancer Drug Targets|October 8, 2003
Development of radicicol analoguesShiro Soga, Yukimasa Shiotsu, Shiro Akinaga, et al.
Nature Reviews. Cancer|February 24, 2007
Epidermal growth factor receptor mutations in lung cancerSreenath V Sharma, Daphne W Bell, Jeffrey Settleman, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Genes & Development|December 15, 2007
Oncogene addiction: setting the stage for molecularly targeted cancer therapySreenath V Sharma, Jeffrey Settleman
Cell Cycle (Georgetown, Tex.)|January 16, 2007
Oncogenic shock: turning an activated kinase against the tumor cellSreenath V Sharma, Jeffrey Settleman
Experimental Cell Research|August 30, 2008
ErbBs in lung cancerSreenath V Sharma, Jeffrey Settleman
Biochemical Pharmacology|March 10, 2010
Exploiting the balance between life and death: targeted cancer therapy and "oncogenic shock"Sreenath V Sharma, Jeff Settleman
Oncogene|April 18, 2002
UCS15A, a novel small molecule, SH3 domain-mediated protein-protein interaction blocking drugChitose Oneyama, Hirofumi Nakano, Sreenath V Sharma
Methods in Enzymology|April 17, 2008
High-throughput lung cancer cell line screening for genotype-correlated sensitivity to an EGFR kinase inhibitorUltan McDermott, Sreenath V Sharma, Jeffrey Settleman
Cell Cycle (Georgetown, Tex.)|October 9, 2010
Allosteric inhibition of BCR-ABLA Quamrul Hassan, Sreenath V Sharma, Markus Warmuth
Nature Reviews. Cancer|March 20, 2010
Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agentsSreenath V Sharma, Daniel A Haber, Jeff Settleman
Current Cancer Drug Targets|October 8, 2003
Development of radicicol analoguesShiro Soga, Yukimasa Shiotsu, Shiro Akinaga, et al.
Nature Reviews. Cancer|February 24, 2007
Epidermal growth factor receptor mutations in lung cancerSreenath V Sharma, Daphne W Bell, Jeffrey Settleman, et al.
Pageof 3